Early cervical cancer and parametrial involvement: is it significant?

Gynecologic Oncology
H SteedW Faught

Abstract

To determine the incidence of parametrial involvement in clinical stage IA and IB1 cervical cancer and whether pelvic lymph node status is a predictor of parametrial status. Retrospective review of 120 patients with FIGO stage IA/IB1 cervical carcinoma treated by class II radical abdominal hysterectomy between January 1997 and December 2001 was performed. The parametria were examined for microscopic involvement of parametrial lymph nodes and/or tissue. Continuous variables were compared using Wilcoxon rank sum test, and Fisher's exact test was used to categorical variables. Kaplan-Meier curves were constructed for overall survival (OS) and recurrence-free survival (RFS). Cox proportional hazards model was used to investigate prognostic factors. One hundred ten patients were eligible. Five patients (5%) had positive parametria and 13 patients (12%) had positive pelvic lymph nodes. Four (80%) patients with positive parametria had positive pelvic lymph nodes. The groups did not differ significantly in terms of age (P = 0.92), histology (P = 0.15), or LVSI (P = 0.20). Positive parametria was associated with larger tumor size (3.0 vs. 2.0 cm, P < 0.05), greater depth of invasion (16 mm vs. 5 mm, P = 0.03), and pelvic lymph node meta...Continue Reading

References

Apr 1, 1987·American Journal of Obstetrics and Gynecology·E BurghardtM Lahousen
Nov 1, 1995·Gynecologic Oncology·J F MagrinaK C Podratz
Sep 1, 1995·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·F. LandoniC. Mangioni
Jan 29, 2002·Gynecologic Oncology·Raimund WinterHellmuth Pickel
Apr 26, 2002·Gynecologic Oncology·Gin-Den ChenHong-Shen Lee
Sep 14, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·R PuenteM T Poblete
Feb 22, 2005·Gynecologic Oncology·Pierluigi Benedetti PaniciCarla Rabitti

❮ Previous
Next ❯

Citations

Apr 6, 2013·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Ying XiongLi-zhi Liang
Oct 27, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Joost R van der VorstAlexander L Vahrmeijer
Jan 27, 2016·Current Treatment Options in Oncology·Federica TomaoFabio Landoni
Nov 8, 2012·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·O GemerO Lavie
Jan 17, 2012·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·F LandoniC Mangioni
Feb 13, 2014·Neurourology and Urodynamics·Rosa M LaterzaHeinz Koelbl
Feb 16, 2011·Gynecologic Oncology·Kathleen M SchmelerPedro T Ramirez
Jan 11, 2011·Gynecologic Oncology·John P DiazNadeem R Abu-Rustum
Jul 29, 2010·Gynecologic Oncology·Mi-Kyung KimSoon-Beom Kang
Mar 6, 2010·The Lancet Oncology·Lukas RobHelena Robova
Jun 21, 2007·BJOG : an International Journal of Obstetrics and Gynaecology·R NaikH Hatem
Dec 12, 2012·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Jaroslav KlatOtakar Kraft
Jul 26, 2012·International Journal of Surgical Oncology·Adelaide Fernanda Ribeiro CubalAna Paula Tavares Branco
Jun 14, 2012·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Lukas RobPetr Skapa
Apr 11, 2012·Gynecologic Oncology·Innocenza PalaiaPierluigi Benedetti Panici
Mar 13, 2014·American Journal of Obstetrics and Gynecology·Jin-Young ParkChan Kyo Kim
Feb 5, 2011·Gynecologic Oncology·Malgorzata LanowskaAchim Schneider
Mar 6, 2015·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Juliana Yoko YonedaLuiz Carlos Zeferino
Jul 19, 2013·Gynecologic Oncology·Clare J ReadeAllan Covens
Sep 1, 2016·Future Oncology·Seiya SatoToru Sugiyama
Oct 6, 2016·European Journal of Cancer Care·A VanichtantikulT Manchana
May 10, 2017·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Federica TomaoFabio Landoni
May 31, 2014·The Cochrane Database of Systematic Reviews·Fani KokkaArjun Jeyarajah
Jul 23, 2015·Journal of Gynecologic Oncology·Hiroyuki YamazakiHidenori Kato
Mar 5, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Hong-Bing CaiHan-Yin Hou
Oct 13, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Tsuyoshi YamashitaKazuo Sengoku
Feb 27, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Waroonsiri HongladarompJatupol Srisomboon
Aug 6, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Vincent BalayaUNKNOWN SENTICOL group
Jun 24, 2009·Obstetrics and Gynecology·Michael FrumovitzPedro T Ramirez
Jul 22, 2010·Expert Review of Anticancer Therapy·Lukas RobHelena Robova
Nov 28, 2017·Archives of Gynecology and Obstetrics·Congcong MaPeishu Liu
Jun 15, 2018·Journal of Translational Medicine·Yohann DabiUNKNOWN Groupe de Recherche FRANCOGYN

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.